Progress of In-stent Restenosis after Vertebral Artery Ostium Stenosis and Imaging Assessments

doi:10.37015/AUDT.2018.180802

Abstract

Abstract:

Stenting has become one of the primary procedure to treat vertebral artery ostium stenosis patients. Postoperative instent restenosis (ISR) of the stenting is still one of the unsolved issues and requires systematic and further investigation. Through imaging assessments, ISR could be identified and evaluated in clinical practice and researches.

Key words: Vertebral; stenosis; stenting; in-stent restenosis; imaging

Jingzhi Li, MD, John R. Eisenbrey, PhD, Yang Hua, MD. Progress of In-stent Restenosis after Vertebral Artery Ostium Stenosis and Imaging Assessments. Advanced Ultrasound in Diagnosis and Therapy, 2018, 2(2): 64-70.

References

[1]	Tank VH, Ghosh R, Gupta V, Sheth N, Gordon S, He W, et al. Drug eluting stents versus bare metal stents for the treatment of extracranial vertebral artery diseas e: a meta-analysis. J Neurointerv Surg 2016; 8:770-4.
[2]	Rangel-Castilla L, Gandhi S, Munich SA, Cress MC, Sonig A, Krishna C, et al. Experience with vertebral artery origin stenting and ostium dilatation: results of treatment and clinical outcomes. J Neurointerv Surg 2016; 8:476-80.
[3]	Zhou Y, Hua Y, Jia L, Wang L, Liu B, Duan C, et al. Evaluation of Interventional Therapy for Patients with Intracranial Vertebral Artery Stenosis by Transcranial Color-Coded Sonography. Ultrasound Med Biol 2016; 42:44-50.
[4]	Savitz SI, Caplan LR. Vertebrobasilar disease. N Engl J Med 2005; 352:2618-26.
[5]	Sundt TM Jr, Smith HC, Campbell JK, Vlietstra RE, Cucchiara RF, Stanson AW. Transluminal angioplasty for basilar artery stenosis. Mayo Clin Proc 1980; 55:673-80.
[6]	Crawley F, Brown MM, Clifton AG, Angioplasty and stenting in the carotid and vertebral arteries. Postgrad Med J 1998; 74:7-10.
[7]	Mahadevia AA, Murphy KPJ. Endovascular treatment of vertebral artery origin lesions. Techniques in vascular and interventional radiology 2005; 8:131-3.
[8]	Edgell RC, Zaidat OO, Gupta R, Abou-Chebl A, Linfante I, Xavier A, et al. Multicenter study of safety in stenting for symptomatic vertebral artery origin stenosis: results from the Society of Vascular and Interventional Neurology Research Consortium. J Neuroimaging 2013; 23:170-4.
[9]	Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL, et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. Developed in collaboration with the American Academy of Neurology and Society of Cardiovascular Computed Tomography. Catheter Cardiovasc Interv 2013; 81:E76-123.
[10]	Jenkins JS, Stewart M2. Endovascular Treatment of Vertebral Artery Stenosis. Prog Cardiovasc Dis 2017; 59:619-25.
[11]	Taylor RA, Siddiq F, Memon MZ, Qureshi AI, Vazquez G, Hayakawa M, et al. Vertebral artery ostial stent placement for atherosclerotic stenosis in 72 consecutive patients: clinical outcomes and follow-up results. Neuroradiology 2009; 51:531-9.
[12]	Jenkins JS, Patel SN, White CJ, Collins TJ, Reilly JP, McMullan PW, et al. Endovascular stenting for vertebral artery stenosis. J Am Coll Cardiol 2010; 55:538-42.
[13]	Hatano T, Tsukahara T, Miyakoshi A, Arai D, Yamaguchi S, Murakami M. Stent placement for atherosclerotic stenosis of the vertebral artery ostium: angiographic and clinical outcomes in 117 consecutive patients. Neurosurgery 2011; 68:108-16.
[14]	Sun X, Ma N, Wang B, Mo D, Gao F, Xu X, et al. The long term results of vertebral artery ostium stenting in a single center. Journal of neurointerventional surgery 2015; 7:888-91.
[15]	Berguer R, Flynn LM, Kline RA, Caplan L. Surgical reconstruction of the extracranial vertebral artery: management and outcome. J Vasc Surg 2000; 31:9-18.
[16]	Ramirez CA, Febrer G, Gaudric J, Abou-Taam S, Beloucif K, Chiche L, et al. Open repair of vertebral artery: a 7-year single-center report. Ann Vasc Surg 2012; 26:79-85.
[17]	Janssens E, Leclerc X, Gautier C, Godefroy O, Koussa M, Hénon H, et al. Percutaneous transluminal angioplasty of proximal vertebral artery stenosis: long-term clinical follow-up of 16 consecutive patients. Neuroradiology 2004; 46:81-4.
[18]	Cloud GC, Crawley F, Clifton A, McCabe DJ, Brown MM, Markus HS. Vertebral artery origin angioplasty and primary stenting: safety and restenosis rates in a prospective series. J Neurol Neurosurg Psychiatry 2003; 74:586-90.
[19]	Song L, Li J, Gu Y, Yu H, Chen B, Guo L, et al. Drug-eluting vs. bare metal stents for symptomatic vertebral artery stenosis. J Endovasc Ther 2012; 19:231-8.
[20]	Coward LJ, McCabe DJ, Ederle J, Featherstone RL, Clifton A, Brown MM, et al. Long-term outcome after angioplasty and stenting for symptomatic vertebral artery stenosis compared with medical treatment in the Carotid And Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomized trial. Stroke 2007; 38:1526-30.
[21]	Compter A, van der Worp HB, Schonewille WJ, Vos JA, Boiten J, Nederkoorn PJ, et al. Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial.The Lancet. Neurology 2015; 14:606-14.
[22]	Storey GS1, Marks MP, Dake M, Norbash AM, Steinberg GK. Vertebral artery stenting following percutaneous transluminal angioplasty. Technical note. Journal of neurosurgery 1996; 84:883-7.
[23]	Matsushita K1, Akai F, Taneda M, Yokoi Y. Stenting for extracranial stenotic lesions of carotid and vertebral arteries. Interventional neuroradiology 1997; 3:53-8.
[24]	Che WQ, Jiang XJ, Dong H, Peng M, Zou YB, Song L, et al. Effect of stenting for the proximal atherosclerotic extracranial vertebral artery stenosis. Zhonghua Xin Xue Guan Bing Za Zhi 2017; 45:34-38.
[25]	Rocha-Singh K. Vertebral artery stenting: ready for prime time? Catheter Cardiovasc Interv 2001; 54:6-7.
[26]	Gupta K. Vertebral artery stenting: not quite ready for prime time! J Am Coll Cardiol 2010; 56:319-20.
[27]	Jayanthi V, Prakash, Devi MN, Geethanjali BS, Rajini T. Anomalous origin of the left vertebral artery from the arch of the aorta: review of the literature and a case report. Folia Morphol (Warsz) 2010; 69:258-60.
[28]	Lemke AJ, Benndorf G, Liebig T, Felix R. Anomalous origin of the right vertebral artery: review of the literature and case report of right vertebral artery origin distal to the left subclavian artery. AJNR Am J Neuroradiol 1999; 20:1318-21.
[29]	Einstein EH, Song LH, Villela NL, Fasani-Feldberg GB, Jacobs JL, Kim DO, et al. Anomalous Origin of the Left Vertebral Artery from the Aortic Arch. Aorta(Stamford) 2016; 4:64-7.
[30]	Stojanovi? B, Vasovi? L, Vlajkovi? S, Trandafilovi? M, Mladenovi? M. Variation of some arteries of the vertebrobasilar system: case report. Surg Radiol Anat 2017; 39:689-92.
[31]	Liu Y, Hua Y, Liu B, Jia L, Jiao L. Anomalous origin of bilateral vertebral arteries from the ICA: review of the literature and a case report. Ann Vasc Surg 2014;28: 1319. e13-6.
[32]	Park JK, Kim SH, Kim BS, Choi G. Two cases of aberrant right subclavian artery and right vertebral artery that originated from the right common carotid artery. Korean J Radiol 2008; 9:S39-42.
[33]	Wholey MH, Wholey MH. The supraaortic and vertebral endovascular interventions. Tech Vasc Interv Radiol 2004; 7:215-25.
[34]	Chuang YM, Chan L, Wu HM, Lee SP, Chu YT. The clinical relevance of vertebral artery hypoplasia. Acta Neurol Taiwan 2012; 21:1-7.
[35]	Feldman RL, Trigg L, Gaudier J, Galat J. Use of coronary Palmaz-Schatz stent in the percutaneous treatment of an intracranial carotid artery stenosis. Cathet Cardiovasc Diagn 1996; 38:316-9.
[36]	Fessler RD, Wakhloo AK, Lanzino G, Qureshi AI, Guterman LR, Hopkins LN. Stent placement for vertebral artery occlusive disease: preliminary clinical experience. Neurosurgical focus, 1998; 5:e15.
[37]	Ko YG, Park S, Kim JY, Min PK, Choi EY, Jung JH, et al. Percutaneous interventional treatment of extracranial vertebral artery stenosis with coronary stents. Yonsei Med J 2004; 45:629-34.
[38]	Boulos AS, Agner C, Deshaies EM. Preliminary evidence supporting the safety of drug-eluting stents in neurovascular disease. Neurological research 2005; 27:S95-102.
[39]	Sharma S, Bhambi B. Vertebral artery stenting utilizing distal embolic protection with filter wire and a drug-eluting Taxus stent. Acute Card Care 2006; 8:235-7.
[40]	Lin YH, Hung CS, Tseng WY, Lee RK, Wang YC, Lin MS, et al. Safety and feasibility of drug-eluting stent implantation at vertebral artery origin: the first case series in Asians. J Formos Med Assoc 2008; 107:253-8.
[41]	Akins PT, Kerber CW, Pakbaz RS. Stenting of vertebral artery origin atherosclerosis in high-risk patients: bare or coated? A single-center consecutive case series. J Invasive Cardiol 2008; 20:14-20.
[42]	Raghuram K, Seynnaeve C, Rai AT. Endovascular treatment of extracranial atherosclerotic disease involving the vertebral artery origins: a comparison of drug-eluting and bare-metal stents. Journal of neurointerventional surgery 2012; 4:206-10.
[43]	Langwieser N, Buyer D, Schuster T, Haller B, Laugwitz KL, Ibrahim T. Bare metal vs. drug-eluting stents for extracranial vertebral artery disease: a meta-analysis of nonrandomized comparative studies. J Endovasc Ther 2014; 21:683-92.
[44]	Zhu QF, Fang SZ, Wang GF, Zhou ZZ, Bian SC, Cui SD, et al. Clinical effects and safety review of self-expanding stent surgery for extracranial carotid artery stenosis treatment. Genet Mol Res 2014; 13:5128-37.
[45]	Wakhloo AK, Tio FO, Lieber BB, Schellhammer F, Graf M, Hopkins LN. Self-expanding nitinol stents in canine vertebral arteries: hemodynamics and tissue response. AJNR Am J Neuroradiol 1995; 16:1043-51.
[46]	Chung SY, Lee DH, Choi JW, Choi BS, In HS, Kim SM, et al. Use of self-expanding stents for the treatment of vertebral artery ostial stenosis: a single center experience. Korean journal of radiology 2010; 11:156-63.
[47]	Li Z, Zhang Y, Hong B, Deng B, Xu Y, Zhao W, et al. Stenting of symptomatic vertebral artery ostium stenosis with self-expanding stents. Journal of clinical neuroscience 2014; 21:274-7.
[48]	Rits J, van Herwaarden JA, Jahrome AK, Krievins D, Moll FL. The incidence of arterial stent fractures with exclusion of coronary, aortic, and non-arterial settings. Eur J Vasc Endovasc Surg 2008; 36:339-45.
[49]	Laird JR. Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the superficial femoral and popliteal arteries. J Endovasc Ther 2006; 13:30-40.
[50]	Canan T, Lee MS. Drug-eluting stent fracture: incidence, contributing factors, and clinical implications. Catheter Cardiovasc Interv 2010; 75:237-45.
[51]	Sfyroeras GS, Koutsiaris A, Karathanos C, Giannakopoulos A, Giannoukas AD. Clinical relevance and treatment of carotid stent fractures. J Vasc Surg 2010; 51:1280-5.
[52]	Ling AJ, Mwipatayi P, Gandhi T, Sieunarine K. Stenting for carotid artery stenosis: fractures, proposed etiology and the need for surveillance. J Vasc Surg 2008; 47:1220-6; discussion 1226.
[53]	Kim SR, Baik MW, Yoo SH, Park IS, Kim SD, Kim MC. Stent fracture and restenosis after placement of a drug-eluting device in the vertebral artery origin and treatment with the stent-in-stent technique. Report of two cases. J Neurosurg 2007; 106:907-11.
[54]	Tsutsumi M, Kazekawa K, Onizuka M, Kodama T, Matsubara S, Aikawa H, et al. Stent fracture in revascularization for symptomatic ostial vertebral artery stenosis. Neuroradiology 2007; 49:253-7.
[55]	Werner M, Br?unlich S, Ulrich M, Bausback Y, Schuster J, Lukhaup A, et al. Drug-eluting stents for the treatment of vertebral artery origin stenosis. J Endovasc Ther 2010; 17:232-40.
[56]	Teraa M, Moll FL, van der Worp BH, Lo RT, de Borst GJ. Symptomatic vertebral artery stent fracture: a case report. J Vasc Interv Radiol 2010; 21:1751-4.
[57]	Tang X, Tang F, Hu C, Wang Q, Long W, Li L. Dynamic Respiratory Tortuosity of the Vertebral Artery Ostium. J Endovasc Ther 2017; 24:124-9.
[58]	Zhou Z, Yin Q, Xu G, Yue X, Zhang R, Zhu W, et al. Influence of vessel size and tortuosity on in-stent restenosis after stent implantation in the vertebral artery ostium. Cardiovascular and interventional radiology 2011; 34:481-7.
[59]	Investigators SS. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 2004; 35:1388-92.
[60]	Wang ZL, Gao BL, Li TX, Cai DY, Zhu LF, Bai WX, et al. Symptomatic intracranial vertebral artery atherosclerotic stenosis (≥70%) with concurrent contralateral vertebral atherosclerotic diseases in 88 patients treated with the intracranial stenting. Eur J Radiol 2015; 84:1801-4.
[61]	Ruparelia N, Chieffo A. Dual antiplatelet therapy following drug-eluting stent implantation: how long is long enough? Expert Rev Cardiovasc Ther 2015; 13:585-7.
[62]	Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, et al. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet 2016; 388:2532-61.
[63]	Pasceri V, Patti G, Nusca A, Pristipino C, Richichi G, Di Sciascio G, et al. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study. Circulation 2004; 110:674-8.
[64]	Di Sciascio G, Patti G, Pasceri V, Gaspardone A, Colonna G, Montinaro A. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial. J Am Coll Cardiol 2009; 54:558-65.
[65]	Nusca A, Melfi R, Di Sciascio G. Percutaneous coronary interventions and statins therapy. Ther Adv Cardiovasc Dis 2008; 2:101-7.
[66]	Reiff T, Amiri H, Rohde S, Hacke W, Ringleb PA. Statins reduce peri-procedural complications in carotid stenting. Eur J Vasc Endovasc Surg 2014; 48:626-32.
[67]	Patti G, Tomai F, Melfi R, Ricottini E, Macrì M, Sedati P, et al. Strategies of clopidogrel load and atorvastatin reload to prevent ischemic cerebral events in patients undergoing protected carotid stenting. Results of the randomized ARMYDA-9 CAROTID (Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting) study. J Am Coll Cardiol 2013; 61:1379-87.
[68]	McDonald AI, Iruela-Arispe ML, Healing arterial ulcers: Endothelial lining regeneration upon vascular denudation injury. Vascul Pharmacol 2015; 72:9-15.
[69]	Jia LY, Hua Y, Yang J, Jiao LQ, Miao ZR. Evaluation of the effect of atorvastatin on preventing restenosis lifter vertebral artery stenting with color Doppler flow hnaging. Chin J Cerebrovasc Dis 2010; 7:449-53.
[70]	Yoon NK, Awad AW, Kalani MY, Taussky P, Park MS. Stent technology in ischemic stroke. Neurosurg Focus 2017; 42:E11.
[71]	Jiang Y, Xu X, Wen Z, Xu X, Yang L, Liu X. In-stent restenosis after vertebral artery stenting. International journal of cardiology 2015; 187:430-3.
[72]	Kono K, Shintani A, Terada T, Non-enhanced magnetic resonance angiography can evaluate restenosis after carotid artery stenting with the Carotid Wallstent. Acta Neurochir (Wien) 2014; 156:1713-9.
[73]	Borisch I, Hamer OW, Zorger N, Feuerbach S, Link J. Borisch.In vivo evaluation of the carotid wallstent on three-dimensional contrast material-enhanced MR angiography: influence of artifacts on the visibility of stent lumina. J Vasc Interv Radiol 2005; 16:669-77.
[74]	Lee YJ, Lim YS, Lim HW, Yu IK, Kim YJ, Yoo WJ. Evaluation of In-Stent Restenosis After Stent Implantation in the Vertebral Artery Ostium by Multislice Computed Tomography Angiography: Factors Affecting Accurate Diagnosis. Clinical neuroradiology 2015; 25:379-86.
[75]	Stayman AN, Nogueira RG, Gupta R. A systematic review of stenting and angioplasty of symptomatic extracranial vertebral artery stenosis. Stroke 2011; 42:2212-6.
[76]	Steinbauer MG, Pfister K, Greindl M, Schlachetzki F, Borisch I, Schuirer G Steinbauer. Alert for increased long-term follow-up after carotid artery stenting: results of a prospective, randomized, single-center trial of carotid artery stenting vs carotid endarterectomy. J Vasc Surg 2008; 48:93-8.
[77]	Jia L, Hua Y, Li J, Duan C, Zhou Y, Jiao L. Optimal ultrasound criteria for defining the severity of vertebral artery in-stent restenosis. Ultrasound Med Biol 2015; 41:775-80.